Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
Abstract This conference report summarized a full-day workshop, "best practices for the development and fit-for-purpose validation of biomarker methods," which was held prior to the American Association of Pharmaceutical Scientists (AAPS) PharmSci360 Congress, San Antonio, TX, November 201...
में बचाया:
| मुख्य लेखकों: | , , , , , , , , , , , , , , |
|---|---|
| स्वरूप: | पुस्तक |
| प्रकाशित: |
SpringerOpen,
2022-02-01T00:00:00Z.
|
| विषय: | |
| ऑनलाइन पहुंच: | Connect to this object online. |
| टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_6add8307c1b945c58fa2e3d151a9d6b7 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Joel Mathews |e author |
| 700 | 1 | 0 | |a Lakshmi Amaravadi |e author |
| 700 | 1 | 0 | |a Steven Eck |e author |
| 700 | 1 | 0 | |a Lauren Stevenson |e author |
| 700 | 1 | 0 | |a Yow-Ming C. Wang |e author |
| 700 | 1 | 0 | |a Viswanath Devanarayan |e author |
| 700 | 1 | 0 | |a John Allinson |e author |
| 700 | 1 | 0 | |a Kelly Lundsten |e author |
| 700 | 1 | 0 | |a Michele Gunsior |e author |
| 700 | 1 | 0 | |a Yan G. Ni |e author |
| 700 | 1 | 0 | |a Marc-Olivier Pepin |e author |
| 700 | 1 | 0 | |a Audrey Gagnon |e author |
| 700 | 1 | 0 | |a Curtis Sheldon |e author |
| 700 | 1 | 0 | |a Paul C. Trampont |e author |
| 700 | 1 | 0 | |a Virginia Litwin |e author |
| 245 | 0 | 0 | |a Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report |
| 260 | |b SpringerOpen, |c 2022-02-01T00:00:00Z. | ||
| 500 | |a 10.1186/s41120-021-00050-1 | ||
| 500 | |a 2364-9534 | ||
| 520 | |a Abstract This conference report summarized a full-day workshop, "best practices for the development and fit-for-purpose validation of biomarker methods," which was held prior to the American Association of Pharmaceutical Scientists (AAPS) PharmSci360 Congress, San Antonio, TX, November 2019. The purpose of the workshop was to bring together thought leaders in biomarker assay development in order to identify which assay parameters and key statistical measures need to be considered when developing a biomarker assay. A diverse group of more than 40 scientists participated in the workshop. The workshop and subsequent working dinner stimulated robust discussion. While a consensus on best practices was not achieved, some common themes and major points to consider for biomarker assay development have been identified and agreed on. The focus of this conference report is to summarize the presentations and discussions which occurred at the workshop. Biomarker assay validation is a complex and an evolving area with discussions ongoing. | ||
| 546 | |a EN | ||
| 690 | |a Biomarker | ||
| 690 | |a Validation | ||
| 690 | |a Fit-for-purpose | ||
| 690 | |a Flow cytometry | ||
| 690 | |a Drug development | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n AAPS Open, Vol 8, Iss 1, Pp 1-7 (2022) | |
| 787 | 0 | |n https://doi.org/10.1186/s41120-021-00050-1 | |
| 787 | 0 | |n https://doaj.org/toc/2364-9534 | |
| 856 | 4 | 1 | |u https://doaj.org/article/6add8307c1b945c58fa2e3d151a9d6b7 |z Connect to this object online. |